By Priscila Mayumi Kashiwabara
14 de February de 2022
Life sciences patent eligibility in Latin America: a guide
Patents are critical to the life sciences industry and often spark intense and heated debate. To be successful, one key strategy that should be pursued by life sciences companies is building and maintaining a patent portfolio capable of distinguishing itself from competitors, as well as representing a well-reasoned business strategy. Companies should secure their patent assets by maximising patent coverage of the core technology and its potential improvements. One reason is that patents can demonstrate the commercial potential of a company’s technology, they are also the driving force for major events in the lifecycle of a life sciences company.
Last by Priscila Mayumi Kashiwabara
1 de July de 2026
INPI Ordinance No. 80/2026 and Second Medical Use Patents
INPI Ordinance No. 80/2026, published on June 30, 2026, in the Official Gazette No. 2895, revised Chapter 9 of the Guidelines for Examination … INPI Ordinance No. 80/2026 and Second Medical Use Patents
29 de May de 2026
Kasznar Leonardos has been ranked by IAM Patent 1000
It is with great honor that we announce that we have once again been ranked in the IAM Patent 1000. In the … Kasznar Leonardos has been ranked by IAM Patent 1000
17 de June de 2025
Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation
On June 11th, 2025, the Brazilian Senate approved Legislative Decree No. 466/2022, ratifying Brazil’s accession to the Budapest Treaty on the International … Brazil Ratifies the Budapest Treaty: A Strategic Step to Strengthen Biotechnological Innovation